Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination

Abstract A phase 1 clinical trial to test the immunogenicity of a chimeric group 1 HA (cHA) universal influenza virus vaccine targeting the conserved stalk domain of the hemagglutinin of influenza viruses was carried out. Vaccination with adjuvanted-inactivated vaccines induced high anti-stalk antib...

Full description

Bibliographic Details
Main Authors: Teresa Aydillo, Ana S. Gonzalez-Reiche, Daniel Stadlbauer, Mary Anne Amper, Venugopalan D. Nair, Chiara Mariottini, Stuart C. Sealfon, Harm van Bakel, Peter Palese, Florian Krammer, Adolfo García-Sastre
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-022-00583-w
_version_ 1797429429197078528
author Teresa Aydillo
Ana S. Gonzalez-Reiche
Daniel Stadlbauer
Mary Anne Amper
Venugopalan D. Nair
Chiara Mariottini
Stuart C. Sealfon
Harm van Bakel
Peter Palese
Florian Krammer
Adolfo García-Sastre
author_facet Teresa Aydillo
Ana S. Gonzalez-Reiche
Daniel Stadlbauer
Mary Anne Amper
Venugopalan D. Nair
Chiara Mariottini
Stuart C. Sealfon
Harm van Bakel
Peter Palese
Florian Krammer
Adolfo García-Sastre
author_sort Teresa Aydillo
collection DOAJ
description Abstract A phase 1 clinical trial to test the immunogenicity of a chimeric group 1 HA (cHA) universal influenza virus vaccine targeting the conserved stalk domain of the hemagglutinin of influenza viruses was carried out. Vaccination with adjuvanted-inactivated vaccines induced high anti-stalk antibody titers. We sought to identify gene expression signatures that correlate with such induction. Messenger-RNA sequencing in whole blood was performed on the peripheral blood of 53 vaccinees. We generated longitudinal data on the peripheral blood of 53 volunteers, at early (days 3 and 7) and late (28 days) time points after priming and boosting with cHAs. Differentially expressed gene analysis showed no differences between placebo and live-attenuated vaccine groups. However, an upregulation of genes involved in innate immune responses and type I interferon signaling was found at day 3 after vaccination with inactivated adjuvanted formulations. Cell type deconvolution analysis revealed a significant enrichment for monocyte markers and different subsets of dendritic cells as mediators for optimal B cell responses and significant increase of anti-stalk antibodies in sera. A significant upregulation of immunoglobulin-related genes was only observed after administration of adjuvanted vaccines (either as primer or booster) with specific induction of anti-stalk IGVH1-69. This approach informed of specific immune signatures that correlate with robust anti-stalk antibody responses, while also helping to understand the regulation of gene expression induced by cHA proteins under different vaccine regimens.
first_indexed 2024-03-09T09:13:03Z
format Article
id doaj.art-8b794dc1a4914540906c55991b10614c
institution Directory Open Access Journal
issn 2059-0105
language English
last_indexed 2024-03-09T09:13:03Z
publishDate 2022-12-01
publisher Nature Portfolio
record_format Article
series npj Vaccines
spelling doaj.art-8b794dc1a4914540906c55991b10614c2023-12-02T08:11:48ZengNature Portfolionpj Vaccines2059-01052022-12-017111410.1038/s41541-022-00583-wTranscriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccinationTeresa Aydillo0Ana S. Gonzalez-Reiche1Daniel Stadlbauer2Mary Anne Amper3Venugopalan D. Nair4Chiara Mariottini5Stuart C. Sealfon6Harm van Bakel7Peter Palese8Florian Krammer9Adolfo García-Sastre10Department of Microbiology, Icahn School of Medicine at Mount SinaiDepartment of Genetics and Genomics Sciences, Icahn School of Medicine at Mount SinaiDepartment of Microbiology, Icahn School of Medicine at Mount SinaiDepartment of Neurology, Icahn School of Medicine at Mount SinaiDepartment of Neurology, Icahn School of Medicine at Mount SinaiDepartment of Microbiology, Icahn School of Medicine at Mount SinaiDepartment of Neurology, Icahn School of Medicine at Mount SinaiDepartment of Genetics and Genomics Sciences, Icahn School of Medicine at Mount SinaiDepartment of Microbiology, Icahn School of Medicine at Mount SinaiDepartment of Microbiology, Icahn School of Medicine at Mount SinaiDepartment of Microbiology, Icahn School of Medicine at Mount SinaiAbstract A phase 1 clinical trial to test the immunogenicity of a chimeric group 1 HA (cHA) universal influenza virus vaccine targeting the conserved stalk domain of the hemagglutinin of influenza viruses was carried out. Vaccination with adjuvanted-inactivated vaccines induced high anti-stalk antibody titers. We sought to identify gene expression signatures that correlate with such induction. Messenger-RNA sequencing in whole blood was performed on the peripheral blood of 53 vaccinees. We generated longitudinal data on the peripheral blood of 53 volunteers, at early (days 3 and 7) and late (28 days) time points after priming and boosting with cHAs. Differentially expressed gene analysis showed no differences between placebo and live-attenuated vaccine groups. However, an upregulation of genes involved in innate immune responses and type I interferon signaling was found at day 3 after vaccination with inactivated adjuvanted formulations. Cell type deconvolution analysis revealed a significant enrichment for monocyte markers and different subsets of dendritic cells as mediators for optimal B cell responses and significant increase of anti-stalk antibodies in sera. A significant upregulation of immunoglobulin-related genes was only observed after administration of adjuvanted vaccines (either as primer or booster) with specific induction of anti-stalk IGVH1-69. This approach informed of specific immune signatures that correlate with robust anti-stalk antibody responses, while also helping to understand the regulation of gene expression induced by cHA proteins under different vaccine regimens.https://doi.org/10.1038/s41541-022-00583-w
spellingShingle Teresa Aydillo
Ana S. Gonzalez-Reiche
Daniel Stadlbauer
Mary Anne Amper
Venugopalan D. Nair
Chiara Mariottini
Stuart C. Sealfon
Harm van Bakel
Peter Palese
Florian Krammer
Adolfo García-Sastre
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination
npj Vaccines
title Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination
title_full Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination
title_fullStr Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination
title_full_unstemmed Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination
title_short Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination
title_sort transcriptome signatures preceding the induction of anti stalk antibodies elicited after universal influenza vaccination
url https://doi.org/10.1038/s41541-022-00583-w
work_keys_str_mv AT teresaaydillo transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT anasgonzalezreiche transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT danielstadlbauer transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT maryanneamper transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT venugopalandnair transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT chiaramariottini transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT stuartcsealfon transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT harmvanbakel transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT peterpalese transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT floriankrammer transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination
AT adolfogarciasastre transcriptomesignaturesprecedingtheinductionofantistalkantibodieselicitedafteruniversalinfluenzavaccination